Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients. (2021)

First Author: Viticchié G

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3791/62130

PubMed Identifier: 33616105

Publication URI: http://europepmc.org/abstract/MED/33616105

Type: Journal Article/Review

Parent Publication: Journal of visualized experiments : JoVE

Issue: 168

ISSN: 1940-087X